Tag Archives: Regulatory Panel Discussion

Resignation from TGACC

My resignation from the Therapeutic Goods Advertising Consultative Committee (TGACC) was precipitated by the non-response of Adj Professor John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health, to long-standing issues raised yet again at the Skepticon 2020 regulatory … Continue reading

Posted in Advertising, Complementary medicine, Medicine policy, Pharmaceutical Promotion, Regulation | Tagged , , , , , , | Leave a comment

Skepticon 2019, TGA, ACCC, Regulatory Panel Discussion

The Australian Skeptics National Convention returned to the University of Melbourne‚Äôs Carrillo Gantner Theatre on 7th and 8th December 2019. One feature was a regulatory panel discussion: Could Australian regulators better protect consumers from misleading and dangerous advertising of products making … Continue reading

Posted in Advertising, Complementary medicine, Medical Devices | Tagged , , , , , , , , | Leave a comment